Lung cancer is a core area of expertise for Worldwide Clinical Trials. We support lung cancer programs from Phase I development through global registrational studies across biomarker-defined patient populations, targeted therapies, immunotherapies, ADCs, and other emerging treatment approaches.
Successfully executing lung cancer trials requires expertise in biomarker-d...